Evidence map›Paper›PMID 26989348›Full record

ArticleThe Cochrane database of systematic reviews

Interventions to improve patient access to and utilisation of genetic and genomic counselling services.

Caroline M Benjamin, Lois H Thomas, Heather Skirton, Shanna Gustafson, Jacqueline Coupe, Christine Patch, Rachel Belk, Svetlana Tishkovskaya, Kathleen Calzone, Katherine Payne

Open access · bronzeAbstract read
In one paragraph

Article in The Cochrane database of systematic reviews. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Caroline M BenjaminSchool of Health, University of Central Lancashire, Preston, UK; Department of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
Lois H ThomasSchool of Health, University of Central Lancashire, Preston, UK.
Heather SkirtonFaculty of Health and Human Sciences, University of Plymouth, Plymouth, UK.
Shanna GustafsonInformedDNA, Saint Petersburg, Florida, USA.
Jacqueline CoupeSchool of Health, University of Central Lancashire, Preston, UK.
Christine PatchDepartment of Clinical Genetics, Guys and St Thomas' NHS Foundation Trust, London, UK.
Rachel BelkManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, UK.
Svetlana TishkovskayaSchool of Health, University of Central Lancashire, Preston, UK.
Kathleen CalzoneCentre for Cancer Research, Genetics Branch, National Cancer Institute, Bethesda, Maryland, USA.
Katherine PayneManchester Centre for Health Economics, The University of Manchester, Manchester, UK.
University of Lancashire · GBGuy's and St Thomas' NHS Foundation Trust · GBNational Cancer Institute · USSt Mary's Hospital · GBSurdna Foundation · USUniversity of Liverpool · GBUniversity of Manchester · GBUniversity of Plymouth · GB

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows. PRIMARY

objectiveThe primary objective is to assess the effectiveness of interventions to improve patient identification, access to and utilisation of genetic and genomic counselling services when compared to: No intervention;Usual or current practice; andOther active intervention. SECONDARY

objectiveThe secondary objective is to explore the resource use and costs associated with interventions aimed at improving patient identification, access to and utilisation of genetic and genomic counselling services from studies meeting the eligibility criteria. We will report on factors that may explain variation in the effectiveness of interventions aimed at improving patient identification, access to and utilisation of genetic and genomic counselling services from studies meeting the eligibility criteria. Another secondary objective is to explore how interventions which target improved patient identification, access to and utilisation of genetic and genomic counselling services affect the subsequent appropriate use of health services for the prevention or early detection of disease. It is also possible that the genetic counselling interaction itself will contribute to the possible use of preventative services.

Identifiers

PMID26989348
PMCPMC4790801
OpenAlexW2244410378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.